Literature DB >> 2440324

"Dedifferentiated" chordoma. A clinicopathologic and immunohistochemical study of three cases.

J M Meis, A K Raymond, H L Evans, R E Charles, A A Giraldo.   

Abstract

Three cases of "dedifferentiated" chordoma arising in the sacrococcygeal region are presented. In all three cases, the "dedifferentiated" component arose de novo in conjunction with conventional chordoma. Two of these patients, whose tumors had a prominent malignant fibrous histiocytoma (MFH) component, died within 6 months of diagnosis. Both patients had lung metastases, one of which was histologically documented to be MFH. The third patient, whose initial tumor contained osteosarcoma, died 76 months after diagnosis and multiple recurrences. Most notable in this case was the absence of the "dedifferentiated" component (in this instance, osteosarcoma) in all of the local recurrences as well as the lung metastases. These were composed exclusively of conventional chordoma. None of the patients had a previous history of radiation therapy. The immunohistochemical staining pattern of conventional chordoma was similar to that of previous reports, where the epithelial-like cells stained for cytokeratin and epithelial membrane antigen. In addition, they stained for alpha-1-anti-chymotrypsin and vimentin. These latter two markers were also identified in the "dedifferentiated" component. As with "dedifferentiated" chondrosarcomas and liposarcomas, "dedifferentiation" in a chordoma usually portends an accelerated clinical course.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440324

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Pathobiology of selected tumors of the base of the skull.

Authors:  L Barnes
Journal:  Skull Base Surg       Date:  1991

Review 2.  Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.

Authors:  Satoshi Kato; Alessandro Gasbarrini; Riccardo Ghermandi; Marco Gambarotti; Stefano Bandiera
Journal:  Eur Spine J       Date:  2016-04-06       Impact factor: 3.134

3.  Update From The 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Nasopharynx.

Authors:  Edward B Stelow; Bruce M Wenig
Journal:  Head Neck Pathol       Date:  2017-02-28

Review 4.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Extra-axial chordomas.

Authors:  S Evans; Z Khan; L Jeys; R Grimer
Journal:  Ann R Coll Surg Engl       Date:  2016-05       Impact factor: 1.891

6.  Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications.

Authors:  R H Hruban; F Traganos; V E Reuter; A G Huvos
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

7.  Dedifferentiated giant cell tumour of bone in the form of low-grade fibroblastic osteogenic sarcoma: case report of a unique presentation with follow-up.

Authors:  A Nahal; A Ajlan; T Alcindor; R Turcotte
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

8.  A case of dedifferentiated solitary fibrous tumor of the thoracic cavity.

Authors:  Yoshio Masuda; Aiko Kurisaki-Arakawa; Kieko Hara; Atsushi Arakawa; Shiaki Oh; Kenji Suzuki; Takashi Yao; Tsuyoshi Saito
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Intracranial chordoma in a neonate.

Authors:  K Oexle; O Dammann; B Bechmann; A O Vortmeyer; E N Probst
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

10.  Chordomas: pathological features; ploidy and silver nucleolar organizing region analysis. A study of 36 cases.

Authors:  K E Schoedel; A J Martinez; T M Mahoney; L Contis; M J Becich
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.